Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $15.00

Aveanna Healthcare (NASDAQ:AVAH) had its price objective boosted by JPMorgan Chase & Co. from $8.00 to $15.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other equities research analysts also recently weighed in on the stock. Raymond James Financial boosted their price objective on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research report on Friday, August 14th. Barclays raised their target price on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a report on Friday, August 28th. BMO Capital Markets upped their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Truist Financial upped their target price on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a report on Monday, August 24th. Finally, Royal Bank Of Canada increased their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research report on Monday, August 24th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $14.06.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock opened at $14.26 on Monday. The company has a market cap of $3.11 billion, a PE ratio of 11.59, a P/E/G ratio of 0.90 and a beta of 1.97. The company has a fifty day moving average price of $11.48 and a two-hundred day moving average price of $8.69. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. Aveanna Healthcare has a 12 month low of $5.93 and a 12 month high of $14.71.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. Research analysts expect that Aveanna Healthcare will post 0.75 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Robert Williams, Jr. sold 14,500,002 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $166,750,023.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the firm’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $143,704,885.50. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 59,904,505 shares of company stock valued at $649,301,514. 5.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Several large investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new position in Aveanna Healthcare during the 2nd quarter valued at $63,504,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Aveanna Healthcare during the 2nd quarter valued at $7,881,000. Braidwell LP raised its stake in shares of Aveanna Healthcare by 39.1% in the 2nd quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock worth $26,268,000 after buying an additional 861,600 shares in the last quarter. Bank of America Corp DE bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth $6,124,000. Finally, Parkman Healthcare Partners LLC acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at $6,123,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Corporation is a provider of home-based healthcare services for children, adults and families in the United States. The company’s services are designed to help patients receive medical and supportive care in their homes and communities, including individuals with complex, chronic or medically fragile conditions.

Aveanna’s principal services include private-duty nursing, home health, hospice and personal care. It also provides pediatric therapy and related clinical services, including physical, occupational and speech therapy.